THE P&R GROUP
P&R Group is one of the major Italian groups in the CHEMICAL-PHARMACEUTICAL INDUSTRY. The Group’s activities are focused on 3 main areas. The Group, with its strong presence in foreign markets through companies and subsidiaries, generates year revenues for approximately € 675 million, of which more than 70% by exports.
Olon S.p.A.’s Mission is to be a world leader in the manufacturing and sales of advanced intermediates and Active Pharmaceutical Ingredients (APIs) for human’s and animal’s health.
WHO WE ARE
Olon S.p.A. is an Italian manufacturer of APIs, with Headquarters and 7 manufacturing facilities located in Italy, and 1 in Spain, originated from the merging of the previous Solmag and Antibioticos, and later by the acquisition of INFA Group. In June 2017, Olon S.p.A. acquired Ricerca Bioscience with a plant in Concord, Ohio, USA. Thanks to the merging and acquisitions, Olon S.p.A. has improved its products portfolio and strengthened its presence in the global market.
Olon S.p.A. has 9 manufacturing facilities, of which 7 are located in Northern Italy, 1 in Spain and 1 in USA (OH). All manufacturing facilities have been designed in compliance with the strictest international requirements and are regularly inspected by the most important national and international Authorities and are also audited by our partners and customers. All are FDA-inspected and self-identified under GDUFA.
Main Therapeutic Classes:
- MAN & WOMAN’s HEALTH